{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By STEVEN DAVIDOFF SOLOMON", "person": [{"middlename": "Davidoff", "firstname": "Steven", "lastname": "SOLOMON", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": "Steven Davidoff Solomon Deal Professor column examines complex takeover battle between rival drug makers Teva and Mylan; observes that Mylan's impending shareholder vote on hostile bid for Perrigo is, in effect, referendum on whether company should allow itself to be acquired by Teva, which vows to withdraw hostile bid if Mylan succeeds in acquisition.", "type_of_material": "News", "word_count": "1352", "lead_paragraph": "The multi-front war between the generic drug makers Teva and Mylan is even more tangled than the usual hostile takeover.", "pub_date": "2015-06-24T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Maneuvers and Dutch Defenses That May Complicate Mylan-Teva Takeover War", "content_kicker": "Deal Professor", "print_headline": "Maneuvers and Dutch Defenses That May Complicate Takeover War", "kicker": "Deal Professor"}, "snippet": "The multi-front war between the generic drug makers Teva and Mylan is even more tangled than the usual hostile takeover.", "multimedia": [{"height": 126, "url": "images/2015/06/24/business/24SUB-DEALPROF/24SUB-DEALPROF-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/06/24/business/24SUB-DEALPROF/24SUB-DEALPROF-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 601, "url": "images/2015/06/24/business/24SUB-DEALPROF/24SUB-DEALPROF-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "601", "xlarge": "images/2015/06/24/business/24SUB-DEALPROF/24SUB-DEALPROF-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/06/24/business/24SUB-DEALPROF/24SUB-DEALPROF-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/06/24/business/24SUB-DEALPROF/24SUB-DEALPROF-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/06/24/business/maneuvers-and-dutch-defenses-that-may-complicate-takeover-war.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Mylan Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Perrigo Company", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "5589f5c038f0d83a0d56bb1d", "source": "The New York Times"}